Clarity in cell line development

Solentim are Recruiting | R&D Director

Company Information: About Solentim Solentim is a Life Sciences company committed to transforming the discovery and development of new biologics, to get materials into the clinic faster and to drive better outcomes for patients. As the global leader in accelerating cell line development through intelligent automation, we create practical solutions to speed up workflows. For …

Read more Solentim are Recruiting | R&D Director

Insights and advances in CRISPR, cell line development and drug discovery

Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be exhibiting at ELRIG’s second CRISPR in Drug Discoveryconference, 4-5 March 2020 at the Babraham Institute in Cambridge. Focusing on the applications of genome engineering throughout the drug discovery pipeline, attendees will gain unique insights into the industry ‘From Targets …

Read more Insights and advances in CRISPR, cell line development and drug discovery

Understanding the latest FDA guidance on investigational new drugs for cell and gene therapy

On the 28th January 2020 we saw the FDA update its guidance for industry regarding chemistry, manufacturing, and control (CMC) on the application of (INDs) for cell and gene therapy, including assurance of clonality and stable cell line development. Innovation driving gene therapy Within this document the FDA provides guidance to the industry and to …

Read more Understanding the latest FDA guidance on investigational new drugs for cell and gene therapy